Literature DB >> 22914643

HLA class I-mediated stress fiber formation requires ERK1/2 activation in the absence of an increase in intracellular Ca2+ in human aortic endothelial cells.

Mary E Ziegler1, Yi-Ping Jin, Steven H Young, Enrique Rozengurt, Elaine F Reed.   

Abstract

Following transplantation, HLA class I antibodies targeting donor endothelium stimulate cell proliferation and migration, which contribute to the development of transplant vasculopathy and chronic allograft rejection. Dynamic remodeling of the actin cytoskeleton regulates cell proliferation and migration in endothelial cells (ECs), but the mechanism(s) involved remain incompletely understood. We explored anti-HLA class I antibody-mediated alterations of the cytoskeleton in human aortic ECs (HAECs) and contrasted these findings to thrombin-induced cytoskeleton remodeling. Our results identify two different signaling pathways leading to myosin light chain (MLC) phosphorylation in HAECs. Stimulation of HAECs with thrombin at 1 U/ml induced a robust elevation of intracellular Ca(2+) concentration, increased MLC phosphorylation, and promoted stress fiber formation via MLC kinase (MLCK) and Rho kinase (ROK) in an ERK-independent manner. In contrast, HAECs stimulated with HLA class I antibodies did not promote any detectable change in intracellular Ca(2+) concentration but instead induced MLC phosphorylation and stress fiber assembly via MLCK and ROK in an ERK1/2-dependent manner. Stimulation of HAECs with low-dose thrombin (1 mU/ml) induced signaling cascades that were similar to stimulation with HLA class I antibodies. HLA class I antibodies also stimulated the translocation of mammalian target of rapamycin complex 2 (mTORC2) and ERK1/2 from the cytoplasm to the plasma membrane independently of stress fiber assembly. These findings identify novel roles for HLA class I signaling in ECs and provide new insights into the role of ERK1/2 and mTORC2 in cytoskeleton regulation, which may be important in promoting transplant vasculopathy, tumor angiogenesis, and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22914643      PMCID: PMC3469712          DOI: 10.1152/ajpcell.00199.2012

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  62 in total

1.  The role of mitogen-activated protein kinase activation within focal adhesions in chemotaxis toward FGF-2 by murine brain capillary endothelial cells.

Authors:  T Shono; H Kanetake; S Kanda
Journal:  Exp Cell Res       Date:  2001-04-01       Impact factor: 3.905

Review 2.  Proteinase-activated receptors.

Authors:  S R Macfarlane; M J Seatter; T Kanke; G D Hunter; R Plevin
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

3.  Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells.

Authors:  C F Lai; L Chaudhary; A Fausto; L R Halstead; D S Ory; L V Avioli; S L Cheng
Journal:  J Biol Chem       Date:  2001-01-29       Impact factor: 5.157

Review 4.  Rho-associated kinase-dependent contraction of stress fibres and the organization of focal adhesions.

Authors:  Kazuo Katoh; Yumiko Kano; Yasuko Noda
Journal:  J R Soc Interface       Date:  2010-09-08       Impact factor: 4.118

5.  Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells.

Authors:  J Zain; Y Q Huang; X Feng; M L Nierodzik; J J Li; S Karpatkin
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

6.  Active ERK/MAP kinase is targeted to newly forming cell-matrix adhesions by integrin engagement and v-Src.

Authors:  V J Fincham; M James; M C Frame; S J Winder
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

7.  mTORC2 regulates neutrophil chemotaxis in a cAMP- and RhoA-dependent fashion.

Authors:  Lunhua Liu; Satarupa Das; Wolfgang Losert; Carole A Parent
Journal:  Dev Cell       Date:  2010-12-14       Impact factor: 12.270

Review 8.  Thrombin signalling and protease-activated receptors.

Authors:  S R Coughlin
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

9.  Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion.

Authors:  D J Webb; D H Nguyen; S L Gonias
Journal:  J Cell Sci       Date:  2000-01       Impact factor: 5.285

10.  Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo.

Authors:  Y Kawano; Y Fukata; N Oshiro; M Amano; T Nakamura; M Ito; F Matsumura; M Inagaki; K Kaibuchi
Journal:  J Cell Biol       Date:  1999-11-29       Impact factor: 10.539

View more
  18 in total

1.  Antibodies to HLA Molecules Mimic Agonistic Stimulation to Trigger Vascular Cell Changes and Induce Allograft Injury.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Curr Transplant Rep       Date:  2015-05-24

2.  Extracellular Matrix Injury of Kidney Allografts in Antibody-Mediated Rejection: A Proteomics Study.

Authors:  Sergi Clotet-Freixas; Caitriona M McEvoy; Ihor Batruch; Chiara Pastrello; Max Kotlyar; Julie Anh Dung Van; Madhurangi Arambewela; Alex Boshart; Sofia Farkona; Yun Niu; Yanhong Li; Olusegun Famure; Andrea Bozovic; Vathany Kulasingam; Peixuen Chen; S Joseph Kim; Emilie Chan; Sajad Moshkelgosha; Syed Ashiqur Rahman; Jishnu Das; Tereza Martinu; Stephen Juvet; Igor Jurisica; Andrzej Chruscinski; Rohan John; Ana Konvalinka
Journal:  J Am Soc Nephrol       Date:  2020-09-08       Impact factor: 10.121

3.  The suppressive effect on CD4 T cell alloresponse against endothelial HLA-DR via PD-L1 induced by anti-A/B ligation.

Authors:  K Iwasaki; H Hamana; H Kishi; T Yamamoto; T Hiramitsu; M Okad; T Tomosugi; A Takeda; S Narumi; Y Watarai; Y Miwa; M Okumura; Y Matsuoka; K Horimi; A Muraguchi; T Kobayash
Journal:  Clin Exp Immunol       Date:  2020-07-18       Impact factor: 4.330

Review 4.  Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms.

Authors:  Nicole M Valenzuela; Jeffrey T McNamara; Elaine F Reed
Journal:  Curr Opin Organ Transplant       Date:  2014-02       Impact factor: 2.640

Review 5.  Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  J Clin Invest       Date:  2017-06-12       Impact factor: 14.808

6.  Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts.

Authors:  Fang Li; Jennifer Wei; Nicole M Valenzuela; Chi Lai; Qiuheng Zhang; David Gjertson; Michael C Fishbein; Jon A Kobashigawa; Mario Deng; Elaine F Reed
Journal:  J Heart Lung Transplant       Date:  2014-10-24       Impact factor: 10.247

7.  Everolimus inhibits anti-HLA I antibody-mediated endothelial cell signaling, migration and proliferation more potently than sirolimus.

Authors:  Y-P Jin; N M Valenzuela; M E Ziegler; E Rozengurt; E F Reed
Journal:  Am J Transplant       Date:  2014-03-01       Impact factor: 8.086

Review 8.  MHC class I signaling: new functional perspectives for an old molecule.

Authors:  E W Tsai; E F Reed
Journal:  Tissue Antigens       Date:  2014-06

9.  An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA.

Authors:  K A Thomas; N M Valenzuela; D Gjertson; A Mulder; M C Fishbein; G C Parry; S Panicker; E F Reed
Journal:  Am J Transplant       Date:  2015-04-22       Impact factor: 8.086

10.  Shear stress regulates late EPC differentiation via mechanosensitive molecule-mediated cytoskeletal rearrangement.

Authors:  Min Cheng; Xiumei Guan; Hong Li; Xiaodong Cui; Xiaoyun Zhang; Xin Li; Xu Jing; Haiyan Wu; Emil Avsar
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.